KLK3 and prostate cancer: Viste Viste E E Vinje Vinje CA CA Lid Lid TG TG Skeie Skeie S S Evjen-Olsen Evjen-Olsen Ø Ø Nordström Nordström T T Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system – the Stavanger experience Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system – the Stavanger experience Scand J Prim Health Care Scand J Prim Health Care 2020 2020 38 38 315 315 22 22 10.1080/02813432.2020.1802139 10.1080/02813432.2020.1802139 32772613 32772613